DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gianni L. Pienkowski T. Im YH. et al.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncol 2012;
13: 25-32
We do not assume any responsibility for the contents of the web pages of other providers.